
(Updated - March 27, 2024 11:43 AM EDT)
Investing.com -- Main U.S. indexes were mixed on Wednesday, with Fed speakers and key inflation data in focus.
Here are some of the biggest U.S. stock movers today:
GameStop (NYSE:GME) slumped 14% after the troubled video game retailer reported disappointing sales for the important holiday quarter, adding it had cut an unspecified number of jobs to reduce costs.
Merck (MRK) stock rose 4% after the pharmaceutical giant’s drug for the treatment of a rare lung disease received approval from the U.S. Food and Drug Administration.
Trump Media&Technology Group (DJT) stock jumped 18%, as the parent company of former President Donald Trump's Truth Social continued to gain after its impressive debut on the Nasdaq.
Robinhood (NASDAQ:HOOD) stock climbed 3%, after the online trading app launched a new credit card in an effort to expand in the personal finance market.
Shockwave Medical (NASDAQ:SWAV) stock rose 2.4%, extending gains after a 10% jump on reports that Johnson&Johnson (NYSE:JNJ) was in talks to buy the medical device maker.
Novocure (NVCR) stock soared 17% after the oncology company said its cancer therapy met the main goal of a late-stage trial testing it as a treatment for a type of lung cancer.
Moderna (NASDAQ:MRNA) stock rose 2% after the biotech firm said it has entered into an agreement with private equity firm Blackstone (NYSE:BX)'s life science investment platform for a funding of $750 million to develop its mRNA flu vaccines.
Lands’ End (LE) stock rose 14% after the clothing retailer said its quarterly sales beat expectations, even as its fourth-quarter loss widened.
Marvell (NASDAQ:MRVL) climbed 4% after Citi analysts opened an upside 30-day catalyst watch on the stock.
Cintas Corp . (NASDAQ:CTAS) climbed 9.5% after the work uniforms provider reported earnings per share and revenue that beat consensus.
Additional reporting by Louis Juricic
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.